查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2010035

支架市場：2026-2032年全球市場預測（依產品類型、材料、輸送方式、應用及最終用戶分類）

Stents Market by Product Type, Material, Mode of Delivery, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，支架市場價值將達到 150.1 億美元，到 2026 年將成長到 161.1 億美元，到 2032 年將達到 253.3 億美元，複合年成長率為 7.75%。

主要市場統計數據
基準年 2025 150.1億美元
預計年份：2026年 161.1億美元
預測年份 2032 253.3億美元
複合年成長率 (%) 7.75%

簡要概述臨床創新、監管要求和醫療保健服務體系的變化如何重塑支架和介入器材的策略。

支架領域在介入醫學、器材工程和醫療保健系統經濟學的交叉領域中發揮著至關重要的作用。材料科學、手術流程和影像技術的進步，已將支架的治療應用範圍從冠狀動脈介入擴展到神經血管、周邊血管、胃腸道和泌尿系統等領域。臨床醫生越來越傾向於選擇微創治療方案，因為這些方案可以縮短恢復時間、降低併發症率，並有可能實現門診治療，從而導致採購重點和醫療服務模式的重組。

材料創新、設計進步和商業平台策略如何推動支架開發和臨床應用的模式轉移。

支架產業正經歷一場變革性的轉型，這主要得益於技術、監管和醫療服務三者之間的協同作用。隨著製造商從傳統的不銹鋼結構轉向採用更先進的合金和聚合物技術，以提升柔軟性、滲透性和生物相容性，材料創新正在重新定義器材的性能。這些材料的進步使得支架的輸送系統更加低矮，植入更加精準，從而能夠更好地適應解剖結構複雜的適應症和複雜的患者群體。

評估近期關稅政策的變化如何重塑整個醫療保健系統的支架供應鏈、製造地和商業性採購趨勢。

美國2025年實施的新關稅政策正促使支架生態系統重新評估其全球製造、採購和定價策略。先前以成本和規模為最佳化目標的供應鏈，如今正因進口關稅對零件和成品經濟效益的影響而接受重新審視。這些關稅壓力正在加速供應商多元化，並重新激發人們對本地製造的興趣，以降低跨境貿易波動風險。

深入了解產品系列、材料選擇、交付系統、臨床用例和醫療保健環境如何相互交織，從而影響技術採用和商業策略。

細分市場層面的趨勢揭示了不同產品類型、材料、交付方式、臨床應用和終端使用者環境的需求促進因素和明確的策略重點。產品種類繁多，涵蓋了從專注於心肌再灌注的冠狀動脈支架到旨在緩解管腔阻塞的胃腸道器械，再到用於頸動脈和顱內應用的消化器官系統支架、用於頸動脈、股動脈、髂動脈和腎動脈疾病的外周支架，甚至包括針對前列腺和輸尿管適應症的泌尿系統支架。每個產品組都有其獨特的操作要求、監管考慮和臨床醫生培訓需求，這些因素都會影響部署計劃和臨床路徑。

影響美洲、歐洲、中東、非洲和亞太地區監管預期、臨床引入模式和生產策略的區域趨勢。

區域趨勢正在影響美洲、歐洲、中東和非洲以及亞太地區的創新軌跡、監管要求和醫療服務提供者的採購慣例。在美洲，臨床醫生在微創介入心臟病學的熟練程度以及主要醫療設備製造商的集中，支持了快速的臨床應用和產品的迭代改進。法律規範強調可靠的臨床數據和上市後監測，這指導產品開發朝著長期療效證據和性能一致性的方向發展。

在支架領域，成熟企業、創新專家和策略夥伴關係如何匯聚一堂，重新定義競爭定位和長期差異化？

支架產業的競爭動態反映了成熟製造商（擁有廣泛的產品系列）與新興專業廠商（引領利基技術）之間的平衡。領先的醫療設備公司持續投資於核心平台的迭代改進，同時透過收購、共同開發契約和銷售夥伴關係等方式拓展鄰近領域。這些措施旨在拓寬臨床適應症、加速監管核准，並整合先進影像技術和輸送系統等互補技術。

為製造商和相關人員提供切實可行的策略建議，以增強支架產業的供應鏈韌性、臨床差異化和商業性價值創造。

產業領導企業應優先考慮多管齊下的策略，將創新、價值鏈韌性和相關人員價值結合。首先，多元化採購和投資軟性製造平台將有助於降低貿易中斷帶來的風險，並隨著市場普及速度的加速而支持快速規模化發展。將部分業務外包到近岸地區，並與契約製造製造商建立策略夥伴關係，可以在保持成本競爭力的同時，提高前置作業時間的可靠性。

採用透明且可重複的調查方法，結合對臨床醫生的訪談、對監管和科學文獻的審查以及可靠的檢驗，以檢驗研究結果。

本研究途徑結合了結構化的初步研究、系統性的二次文獻回顧和嚴謹的檢驗，以確保研究結果的可靠性和有效性。初步研究包括對介入臨床醫生、採購經理、監管專家和器材工程師進行詳細訪談，以識別實際臨床挑戰、推動器材應用和未滿足的臨床需求。這些訪談提供了不同醫療機構中手術流程、器械選擇標準和操作限制等方面的背景資訊。

對臨床證據、製造靈活性和生態系統協作如何決定不斷發展的支架市場中的競爭贏家進行綜合分析。

支架技術和商業化正進入以臨床療效、營運可行性和供應鏈韌性主導的「可操作創新」階段。材料和輸送系統的進步正在拓展血管、神經血管、胃腸道和泌尿系統領域的治療可能性，同時監管和報銷環境也正將重點轉向長期療效和可驗證的價值。醫療服務提供者和保險公司越來越重視產品的持久性和成本效益，這凸顯了整合資料策略和以結果主導的產品定位的重要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：支架市場：依產品類型分類

  • 冠狀動脈支架
  • 胃腸道支架
  • 神經血管支架
    • 顱外頸動脈支架
    • 顱內支架
  • 外周支架
    • 頸動脈支架
    • 股動脈支架
    • 髂動脈支架
    • 腎動脈支架
  • 泌尿系統支架
    • 攝護腺支架
    • 輸尿管支架

第9章：支架市場：依材料分類

  • 金屬支架
    • 鈷鉻合金
    • 鎳鈦諾
    • 鉑金鉻
    • 不銹鋼
  • 聚合物支架
    • 可生物分解聚合物
    • 不可生物分解聚合物

第10章：支架市場依輸送方式分類

  • 球囊擴張型支架
  • 自動擴張型支架

第11章：支架市場：依應用領域分類

  • 心血管疾病
  • 胃腸道阻塞
  • 神經血管疾病
  • 腫瘤相關應用
  • 周邊動脈疾病（PAD）
  • 泌尿系統疾病

第12章：支架市場：依最終用戶分類

  • 門診手術中心（ASC）
  • 循環系統中心
  • 醫院
  • 專科診所

第13章：支架市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：支架市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 支架市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國支架市場

第17章：中國支架市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cook Medical LLC
  • Cordis Corporation
  • Elixir Medical Corporation
  • Endologix LLC
  • InspireMD, Inc.
  • Lepu Medical Technology Co., Ltd
  • Medinol Ltd.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd
  • MicroPort Scientific Corporation
  • Sahajanand Medical Technologies Pvt. Ltd
  • Shanghai MicroPort Medical（Group）Co., Ltd
  • STENTYS SA
  • Terumo Corporation
  • WL Gore & Associates, Inc.
Product Code: MRR-434CCDA04EF3

The Stents Market was valued at USD 15.01 billion in 2025 and is projected to grow to USD 16.11 billion in 2026, with a CAGR of 7.75%, reaching USD 25.33 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 15.01 billion
Estimated Year [2026] USD 16.11 billion
Forecast Year [2032] USD 25.33 billion
CAGR (%) 7.75%

A concise strategic overview of how clinical innovation, regulatory demands, and care delivery shifts are reshaping stents and interventional device strategies

The stents landscape occupies a pivotal role at the intersection of interventional medicine, device engineering, and health system economics. Advances in materials science, procedural techniques, and imaging technologies have broadened the therapeutic applications of stents beyond coronary interventions to encompass neurovascular, peripheral, gastrointestinal, and urological contexts. Clinicians increasingly favor minimally invasive options that shorten recovery, lower complication rates, and enable outpatient pathways, which in turn reshapes procurement priorities and care delivery models.

Industry participants operate within a complex regulatory and reimbursement environment that demands rigorous clinical evidence and post-market surveillance. Regulatory pathways now emphasize long-term safety and real-world performance, prompting manufacturers to integrate data generation into product strategies. Concurrently, provider systems are exploring value-based contracting and outcome-linked procurement, which raises the bar for comparative clinical benefit and cost-effectiveness.

This report synthesizes technological, clinical, and commercial signals to outline where innovation is creating differentiated value and where operational pressures are prompting strategic realignment. It intends to provide leaders with a clear baseline of contemporary dynamics, enabling them to prioritize investment, optimize supply chains, and refine go-to-market approaches in response to evolving stakeholder expectations.

How materials breakthroughs, design evolution, and commercial platform strategies are driving a paradigm shift in stents development and clinical adoption

The stents landscape is experiencing transformative shifts driven by converging forces across technology, regulation, and healthcare delivery. Materials innovation is redefining device performance as manufacturers move from traditional stainless steel constructs toward advanced alloys and polymer technologies that offer improved flexibility, radiopacity, and biological compatibility. These material advances enable lower-profile delivery systems and more precise deployment, which supports expansion into anatomically challenging indications and complex patient cohorts.

Concurrently, device design is aligning more closely with physiologic preservation and restenosis mitigation. Drug-eluting coatings, bioresorbable scaffolds, and surface engineering techniques aim to minimize neointimal proliferation while preserving vessel integrity. These design trends are complemented by improvements in imaging and navigation tools, which facilitate highly targeted interventions and reduce procedural variability. The interplay between device performance and procedural precision has important implications for training, procedural guidelines, and clinical adoption.

On the commercial front, consolidation among suppliers and strategic partnerships with technology firms are accelerating platform-based approaches that combine hardware with data-driven services. Reimbursement models are shifting toward value recognition, encouraging manufacturers to demonstrate long-term outcomes rather than focusing solely on peri-procedural metrics. At the same time, the provider landscape is decentralizing with greater adoption of ambulatory surgical centers and specialty clinics for selected procedures, prompting manufacturers to develop simplified systems and service models that support outpatient workflows.

Regulatory authorities are reinforcing post-market evidence requirements and real-world data collection, which increases the need for integrated registries and longitudinal follow-up. In response, manufacturers are investing in data infrastructure, remote monitoring, and stakeholder engagement strategies. In short, the industry is transitioning from single-product innovation toward integrated solutions that combine materials, procedural systems, data, and service models to deliver demonstrable clinical and economic value.

Assessment of how recent tariff policy changes are reshaping stents supply chains, manufacturing footprints, and commercial procurement dynamics across healthcare systems

The introduction of new tariff policies in the United States in 2025 has prompted a reassessment of global manufacturing, sourcing, and pricing strategies within the stents ecosystem. Supply chains that were previously optimized for cost and scale are experiencing renewed scrutiny as import levies affect component and finished-device economics. These tariff pressures have accelerated diversification of supplier bases and reignited interest in regional manufacturing to reduce exposure to cross-border trade volatility.

Manufacturers with vertically integrated capabilities or flexible production footprints have found it easier to adapt, while firms reliant on specialized overseas component suppliers have faced increased input cost volatility. In response, many companies are negotiating longer-term agreements, relocating certain manufacturing steps closer to end markets, and exploring toll-manufacturing arrangements to spread fixed costs and maintain continuity of supply. These operational moves are altering capital allocation decisions and influencing where R&D investments are directed.

Procurement teams within hospitals and health systems have also adjusted sourcing strategies to mitigate pass-through cost increases. Some providers have recalibrated device selection protocols and engaged in tighter contract negotiations, while others have pursued group purchasing arrangements to preserve access to preferred technologies. Payers and health technology assessors have been attentive to any implications for total procedure cost and long-term outcomes, which has amplified the need for transparency in pricing and demonstrated value propositions.

Importantly, the tariff environment has created an incentive for domestic and nearshore manufacturing investment, supporting policy conversations around medical device sovereignty and supply chain resilience. At the same time, the heightened cost environment may spur incremental innovation focused on materials efficiency, modular manufacturing, and reusable tooling. Overall, the cumulative impact of tariff changes is less a one-time shock and more a catalyst for structural shifts in sourcing, manufacturing strategy, and commercial engagement across the stents sector.

Insights into how product families, material choices, delivery systems, clinical use cases, and care settings collectively shape technology adoption and commercial strategy

Segment-level dynamics reveal differentiated demand drivers and distinct strategic priorities across product categories, materials, delivery modes, clinical applications, and end-user settings. Product diversity ranges from coronary stents focused on myocardial revascularization to gastrointestinal devices aimed at relieving luminal obstruction, neurovascular stents designed for carotid and intracranial applications, peripheral stents that address carotid, femoral, iliac, and renal arterial disease, as well as urological stents tailored to prostatic and ureteral indications. Each product family carries unique procedural requirements, regulatory considerations, and clinician training needs, which influences adoption timelines and clinical pathways.

Material choice exerts a foundational influence on device behavior, with metallic stents constructed from alloys such as cobalt chromium, nitinol, platinum chromium, and stainless steel delivering established radial strength and fatigue resistance for demanding vascular territories. Polymeric alternatives, including biodegradable and non-biodegradable polymer compositions, present opportunities for temporary scaffolding that could reduce long-term implant burden and facilitate future interventions. Material innovations also intersect with coating strategies and drug-elution technologies, shaping healing responses and long-term vessel patency profiles.

Mode of delivery is a central determinant of clinical use cases and procedure setting, with balloon-expandable systems traditionally used where precise deployment and high radial force are required, while self-expanding platforms offer conformability in tortuous or dynamic vascular segments. These differences impact device sizing algorithms, imaging requirements, and operator learning curves. Clinical application areas span cardiovascular disease leading to coronary interventions, gastrointestinal obstructions that require luminal patency restoration, neurovascular conditions demanding delicate intracranial navigation, oncology-related uses where stents support tumor-related obstruction management, peripheral artery disease where limb salvage and symptom alleviation are priorities, and urological disorders focusing on urinary drainage and obstruction relief.

End-user environments further modulate product requirements and commercial approaches. Ambulatory surgical centers and specialty clinics increasingly demand devices that enable shorter procedure times, simplified logistics, and predictable recovery, whereas hospitals and cardiology centers prioritize comprehensive product portfolios, integration with complex imaging suites, and robust support for high-acuity cases. Understanding how each segmentation axis interacts is essential for tailoring clinical evidence generation, training programs, and commercial models that align with specific stakeholder needs.

Regional dynamics affecting regulatory expectations, clinical adoption patterns, and manufacturing strategies across the Americas, Europe Middle East & Africa, and Asia-Pacific

Geographic dynamics influence innovation trajectories, regulatory requirements, and provider procurement practices across the Americas, Europe Middle East & Africa, and Asia-Pacific regions. In the Americas, clinician familiarity with minimally invasive cardiovascular interventions and a concentrated base of leading device manufacturers supports rapid clinical adoption and iterative product improvement. Regulatory frameworks emphasize robust clinical data and post-market surveillance, which steers product development toward long-term outcome evidence and performance consistency.

In Europe, the Middle East, and Africa, regulatory harmonization efforts coexist with regional variations that affect time-to-market and local clinical practice patterns. Several markets within this broad region demonstrate strong clinical research networks and advanced interventional capabilities, while others are focused on expanding access and building procedural capacity. Providers in this region often balance cost considerations with the desire for proven clinical benefit, shaping procurement strategies and local distributor models.

The Asia-Pacific landscape is characterized by diverse healthcare systems, rapidly expanding interventional capability in key markets, and an active manufacturing ecosystem that supplies both regional and global demand. Innovation hubs in this region are contributing to device engineering advances and high-volume, cost-sensitive production. More broadly, each region presents distinct opportunities for clinical partnerships, localized manufacturing investments, and tailored go-to-market approaches that reflect reimbursement structures, provider capabilities, and patient demographics.

How incumbent firms, specialized innovators, and strategic partnerships are converging to redefine competitive positioning and long term differentiation in stents

Competitive dynamics in the stents arena reflect a balance between entrenched manufacturers with broad portfolios and emerging specialists advancing niche technologies. Leading device companies continue to invest in iterative improvements to core platforms while seeking adjacent expansion through acquisitions, co-development agreements, and distribution partnerships. These efforts aim to broaden clinical indications, accelerate regulatory approvals, and integrate complementary technologies such as advanced imaging and delivery systems.

Smaller and mid-sized innovators often focus on specialized materials, novel drug-eluting chemistries, or unique delivery mechanisms that address unmet clinical needs or simplify procedures. Strategic collaborations between incumbents and innovators are increasingly common, enabling rapid scale-up of promising technologies and shared access to clinical trial networks. In parallel, contract manufacturers and component suppliers play a critical role in enabling speed-to-market and flexible production, especially as firms respond to supply chain pressures.

Commercial differentiation increasingly depends on demonstrating longitudinal patient benefits and offering service-oriented solutions such as training programs, registry support, and performance analytics. Companies that successfully combine clinical excellence with operational support and transparent value communication tend to gain preferential positioning with large provider systems. Continued M&A activity, selective partnership models, and investments in post-market evidence generation will shape competitive positioning in the near term.

Practical strategic prescriptions for manufacturers and stakeholders to strengthen supply resilience, clinical differentiation, and commercial value capture in stents

Industry leaders should prioritize a multi-dimensional strategy that aligns innovation with supply chain resilience and stakeholder value. First, investing in diversified sourcing and flexible manufacturing platforms reduces exposure to trade disruptions and supports rapid scaling when adoption accelerates. Nearshoring selected operations and developing strategic partnerships with contract manufacturers can preserve cost competitiveness while improving lead-time reliability.

Second, accelerating materials and coating research that demonstrably improves long-term clinical outcomes will be critical to securing favorable procurement positioning. Demonstrations of reduced restenosis, lower complication rates, and simplified reintervention pathways will resonate with payers and large provider systems. Integrating robust real-world data collection and registries into product launches will support these claims and facilitate value-based contracting discussions.

Third, tailor commercial approaches to end-user environments by designing devices and service models that meet the specific needs of ambulatory surgical centers, specialty clinics, and high-acuity hospitals. Simplified systems that reduce procedure time and logistics burden are likely to find traction in outpatient settings, while comprehensive portfolio support and integration with imaging ecosystems will be essential for tertiary centers.

Fourth, proactively address regulatory and reimbursement evolution by engaging early with authorities, aligning clinical programs to long-term performance endpoints, and preparing transparent pricing models that articulate total cost of care benefits. Finally, cultivate partnerships across the ecosystem - including imaging firms, digital health providers, and academic centers - to build platform solutions that combine hardware with data and services, thereby creating defensible differentiation and stronger commercial value propositions.

A transparent and reproducible methodology combining clinician interviews, regulatory and scientific literature review, and robust triangulation to validate insights

The research approach combined structured primary inquiry, systematic secondary review, and rigorous triangulation to ensure reliability and relevance. Primary research consisted of in-depth interviews with interventional clinicians, procurement leaders, regulatory experts, and device engineers to surface real-world challenges, adoption drivers, and unmet clinical needs. These conversations provided context on procedural workflows, device preferences, and the operational constraints of different care settings.

Secondary research included peer-reviewed literature, regulatory guidance documents, clinical trial registries, and company disclosures to map technological trends, material science developments, and competitive activities. Publicly available regulatory filings and guidance informed the assessment of evidence expectations and approval pathways. The integration of these sources enabled identification of convergent signals and informed scenario analysis around supply chain and commercial impacts.

Data synthesis involved cross-validation between interview insights and documentary evidence, followed by qualitative coding to extract thematic patterns across product segments, materials, delivery systems, clinical applications, and geographic regions. The methodology emphasized transparency and reproducibility, with key assumptions and limitations explicitly documented. Stakeholder validation sessions were conducted to refine findings and ensure practical applicability for commercial and clinical decision-makers.

Synthesis of how clinical evidence, manufacturing agility, and ecosystem collaboration will determine competitive winners in the evolving stents landscape

Stents technology and commercialization are entering a phase of pragmatic innovation where clinical efficacy, operational feasibility, and supply chain resilience will determine leadership. Advances in materials and delivery systems are expanding therapeutic possibilities across vascular, neurovascular, gastrointestinal, and urological domains, while regulatory and reimbursement environments are shifting focus toward long-term outcomes and demonstrable value. Providers and payers increasingly expect evidence of durability and cost-efficiency, which places a premium on integrated data strategies and outcome-driven product positioning.

The cumulative effect of recent trade policy shifts and changing provider care models underscores the importance of adaptive manufacturing strategies and targeted commercial approaches. Firms that align technical innovation with resilient operations and clear value articulation will be best positioned to capture momentum. Collaboration across the ecosystem - from imaging partners to academic networks and payers - will accelerate adoption and support the shift toward platform-based solutions that combine devices with data and services.

Overall, the period ahead favors organizations that combine rigorous clinical evidence, agile manufacturing, and customer-centric commercial models to deliver measurable improvements in patient outcomes and provider efficiency. Those who act decisively to integrate these elements into cohesive strategies will create enduring competitive advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Stents Market, by Product Type

  • 8.1. Coronary Stents
  • 8.2. Gastrointestinal Stents
  • 8.3. Neurovascular Stents
    • 8.3.1. Extracranial Carotid Artery Stents
    • 8.3.2. Intracranial Stents
  • 8.4. Peripheral Stents
    • 8.4.1. Carotid Artery Stents
    • 8.4.2. Femoral Artery Stents
    • 8.4.3. Iliac Artery Stents
    • 8.4.4. Renal Artery Stents
  • 8.5. Urological Stents
    • 8.5.1. Prostatic Stents
    • 8.5.2. Ureteral Stents

9. Stents Market, by Material

  • 9.1. Metallic Stents
    • 9.1.1. Cobalt Chromium
    • 9.1.2. Nitinol
    • 9.1.3. Platinum Chromium
    • 9.1.4. Stainless Steel
  • 9.2. Polymeric Stents
    • 9.2.1. Biodegradable Polymers
    • 9.2.2. Non-biodegradable Polymers

10. Stents Market, by Mode of Delivery

  • 10.1. Balloon-Expandable Stents
  • 10.2. Self-Expanding Stents

11. Stents Market, by Application

  • 11.1. Cardiovascular Diseases
  • 11.2. Gastrointestinal Obstructions
  • 11.3. Neurovascular Conditions
  • 11.4. Oncology-Related Applications
  • 11.5. Peripheral Artery Disease (PAD)
  • 11.6. Urological Disorders

12. Stents Market, by End User

  • 12.1. Ambulatory Surgical Centers (ASCs)
  • 12.2. Cardiology Centers
  • 12.3. Hospitals
  • 12.4. Specialty Clinics

13. Stents Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Stents Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Stents Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Stents Market

17. China Stents Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. B. Braun Melsungen AG
  • 18.7. Becton, Dickinson and Company
  • 18.8. BIOTRONIK SE & Co. KG
  • 18.9. Boston Scientific Corporation
  • 18.10. Cook Medical LLC
  • 18.11. Cordis Corporation
  • 18.12. Elixir Medical Corporation
  • 18.13. Endologix LLC
  • 18.14. InspireMD, Inc.
  • 18.15. Lepu Medical Technology Co., Ltd
  • 18.16. Medinol Ltd.
  • 18.17. Medtronic plc
  • 18.18. Meril Life Sciences Pvt. Ltd
  • 18.19. MicroPort Scientific Corporation
  • 18.20. Sahajanand Medical Technologies Pvt. Ltd
  • 18.21. Shanghai MicroPort Medical (Group) Co., Ltd
  • 18.22. STENTYS SA
  • 18.23. Terumo Corporation
  • 18.24. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL STENTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL STENTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL STENTS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL STENTS MARKET SIZE, BY MODE OF DELIVERY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL STENTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL STENTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL STENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL STENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL STENTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA STENTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL STENTS MARKET SIZE, BY CORONARY STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL STENTS MARKET SIZE, BY CORONARY STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL STENTS MARKET SIZE, BY CORONARY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL STENTS MARKET SIZE, BY EXTRACRANIAL CAROTID ARTERY STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL STENTS MARKET SIZE, BY EXTRACRANIAL CAROTID ARTERY STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL STENTS MARKET SIZE, BY EXTRACRANIAL CAROTID ARTERY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL STENTS MARKET SIZE, BY INTRACRANIAL STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL STENTS MARKET SIZE, BY INTRACRANIAL STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL STENTS MARKET SIZE, BY INTRACRANIAL STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL STENTS MARKET SIZE, BY CAROTID ARTERY STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL STENTS MARKET SIZE, BY CAROTID ARTERY STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL STENTS MARKET SIZE, BY CAROTID ARTERY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL STENTS MARKET SIZE, BY FEMORAL ARTERY STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL STENTS MARKET SIZE, BY FEMORAL ARTERY STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL STENTS MARKET SIZE, BY FEMORAL ARTERY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL STENTS MARKET SIZE, BY ILIAC ARTERY STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL STENTS MARKET SIZE, BY ILIAC ARTERY STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL STENTS MARKET SIZE, BY ILIAC ARTERY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL STENTS MARKET SIZE, BY RENAL ARTERY STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL STENTS MARKET SIZE, BY RENAL ARTERY STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL STENTS MARKET SIZE, BY RENAL ARTERY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL STENTS MARKET SIZE, BY PROSTATIC STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL STENTS MARKET SIZE, BY PROSTATIC STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL STENTS MARKET SIZE, BY PROSTATIC STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL STENTS MARKET SIZE, BY URETERAL STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL STENTS MARKET SIZE, BY URETERAL STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL STENTS MARKET SIZE, BY URETERAL STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL STENTS MARKET SIZE, BY METALLIC STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL STENTS MARKET SIZE, BY METALLIC STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL STENTS MARKET SIZE, BY METALLIC STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL STENTS MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL STENTS MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL STENTS MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL STENTS MARKET SIZE, BY NITINOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL STENTS MARKET SIZE, BY NITINOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL STENTS MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL STENTS MARKET SIZE, BY PLATINUM CHROMIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL STENTS MARKET SIZE, BY PLATINUM CHROMIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL STENTS MARKET SIZE, BY PLATINUM CHROMIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL STENTS MARKET SIZE, BY POLYMERIC STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL STENTS MARKET SIZE, BY POLYMERIC STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL STENTS MARKET SIZE, BY POLYMERIC STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL STENTS MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL STENTS MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL STENTS MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL STENTS MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL STENTS MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL STENTS MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL STENTS MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL STENTS MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL STENTS MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL STENTS MARKET SIZE, BY SELF-EXPANDING STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL STENTS MARKET SIZE, BY SELF-EXPANDING STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL STENTS MARKET SIZE, BY SELF-EXPANDING STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL STENTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL STENTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL STENTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL OBSTRUCTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL OBSTRUCTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL OBSTRUCTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR CONDITIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR CONDITIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR CONDITIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL STENTS MARKET SIZE, BY ONCOLOGY-RELATED APPLICATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL STENTS MARKET SIZE, BY ONCOLOGY-RELATED APPLICATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL STENTS MARKET SIZE, BY ONCOLOGY-RELATED APPLICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL ARTERY DISEASE (PAD), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL ARTERY DISEASE (PAD), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL ARTERY DISEASE (PAD), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL STENTS MARKET SIZE, BY CARDIOLOGY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL STENTS MARKET SIZE, BY CARDIOLOGY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL STENTS MARKET SIZE, BY CARDIOLOGY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL STENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL STENTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL STENTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL STENTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL STENTS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL STENTS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS STENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. GCC STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. GCC STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. GCC STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 215. GCC STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 216. GCC STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 217. GCC STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 218. GCC STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 219. GCC STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 220. GCC STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 221. GCC STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. GCC STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. G7 STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 246. G7 STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. G7 STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 248. G7 STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 249. G7 STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 250. G7 STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 251. G7 STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 252. G7 STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 253. G7 STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 254. G7 STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 255. G7 STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. NATO STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 257. NATO STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. NATO STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 259. NATO STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 260. NATO STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 261. NATO STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 262. NATO STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 263. NATO STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 264. NATO STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 265. NATO STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. NATO STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. GLOBAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 286. CHINA STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 287. CHINA STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 289. CHINA STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)